The DOI matches its Crossref record; 26 of the 27 references it cites were found in a registry or an index; 10 of the 19 sources its claims cite were checked for support.
Real‐World Evaluation of the BioFire FilmArray ME Panel: Diagnostic Accuracy and Clinical Utility
Open accessAbstract
Large real-world cohort of 955 patients showing 8.4% positivity and strong diagnostic performance for the BioFire ME panel.
Overview
CoChat Summary
TL;DR
In a single-center real-world cohort of 955 patients with suspected CNS infection, the BioFire FilmArray ME panel showed high overall sensitivity (94.8%) and specificity (99.4%). It detected pathogens in 8.4% of patients, but false-negative bacterial results, clinically insignificant viral detections, and infections due to organisms outside the panel indicate it should complement, not replace, conventional diagnostics.
Key findings
- Among 955 unique patients (35.6% pediatric, 64.4% adults; mean age 34.6 years), panel positivity was 8.4%. The most common bacterial pathogen was *S. pneumoniae* (28.7% of positive cases), followed by *H. influenzae* (7.5%) and *N. meningitidis* (6.2%); viral detections were led by Enterovirus (15%) and HSV-1 (13.7%).
- Overall sensitivity was 94.8% and specificity 99.4%; in pediatric patients, sensitivity/specificity were 91.6%/99.6%, and in adults, 97.6%/99.1%. PPV was 97.3% for bacterial pathogens (36 TP, 1 FP), 90.0% for viral agents (36 TP, 4 FP), and 100% for fungal agents (2 TP, 0 FP).
- Four false-negative results were all bacterial and involved *E. coli* (2) or *S. pneumoniae* (2), both included in the panel. Five false-positive results included *H. influenzae* (1), Enterovirus (2), and HHV-6 (2).
- Bacterial pathogens not included in the panel were detected in 38 patients, most commonly *Acinetobacter baumannii* (42.8%) and *Stenotrophomonas maltophilia* (20%); *M. tuberculosis* was detected in 3 patients.
Methods
- Ambidirectional cohort conducted at Şahinbey Research and Application Hospital, a tertiary university hospital in southeastern Türkiye, from February 2018 to October 2025. Patients were included if they underwent lumbar puncture for suspected CNS infection and the BioFire ME panel was requested.
- CSF culture was the reference standard for bacterial and fungal pathogens. For viral infections, reference classification used a composite assessment of CSF biochemistry, CSF cytology, clinical features, pathogen-directed antiviral therapy, elevated CRP, and supportive radiological findings. Discordant results were reviewed by two investigators.
- Sensitivity was calculated as 100 × (TP/[TP + FN]), specificity as 100 × (TN/[TN + FP]), and PPV as TP/(TP + FP); two-sided 95% CIs were computed using the exact binomial method based on the Wilson score method.
Limitations
- The paper states that the viral reference method was not a definitive gold standard, no third arbiter method such as next-generation sequencing was used for discordant results, the study relied on single-center data, the retrospective design introduced susceptibility to incomplete records and unrecognized confounders, and limited subgroup sample sizes plus possible selection bias may have influenced outcomes.
- The paper states that the fungal PPV of 100% was based on only two positive fungal cases, requiring cautious interpretation.
- Evident from the text: false-negative and false-positive discordance, plus the substantial proportion of infections caused by organisms outside the panel, indicate the assay should not replace conventional culture or broader diagnostic workups, particularly in patients with implanted devices, neurosurgical interventions, or intensive care–related risks.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
8 Valid · 0 Not valid · 8 Not checked · 33 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In the pre‐FDA evaluation, the PPV was substantially lower for several targets, including E. coli K1, S. agalactiae, S. pneumoniae, CMV, HSV‐1, and C. neoformans/C. gattii (6).”
§ Real‐World Evaluation of the BioFire FilmArray ME Panel: Diagnostic Accuracy and Clinical Utility > 4. Discussion
What the sources say
- Partly supportedcites [6] Leber A. L., Everhart K., Balada-Llasat J. M. et al., Multicenter Evaluation of Biofire Filmarray Meningitis/Encephalitis Panel for Detection of Bacteria, Viruses, and Yeast in Cerebrospinal Fluid Specimens, Journal of Clinical Microbiology. (2016) 54, no. 9, 2251– 2261, 10.1128/JCM.00730-16, 2-s2.0-84982129304. 27335149 PMC5005480 sourceExperimental — accuracy not yet measured
Results Table 3 reports true-positive and false-positive counts that imply relatively low proportions of comparator-confirmed positive results for all six listed targets. But Materials and Methods (Calculations and statistical analysis; page not available) explicitly says positive predictive values could not be calculated because final clinical diagnoses were not collected for all specimens. The claim therefore treats comparator-based proportions as PPVs the paper did not report. (LLM, conf=0.87)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Sensitivity was 91.6% in children and 97.6% in adults”
- Also stated in: § 3. Results · plain
“whereas in adults, sensitivity increased to 97.6% with a specificity of 99.1%”
§ Real‐World Evaluation of the BioFire FilmArray ME Panel: Diagnostic Accuracy and Clinical Utility > Abstract
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Also stated in: § 3. Results · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Overall sensitivity and specificity were 94.8% and 99.4%.”
- Also stated in: § 3. Results · plain
“Overall test performance was high, with a sensitivity of 94.8% and a specificity of 99.4%.”
§ Real‐World Evaluation of the BioFire FilmArray ME Panel: Diagnostic Accuracy and Clinical Utility > Abstract
plainn = 955- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Also stated in: § 3. Results · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Overall sensitivity and specificity were 94.8% and 99.4%.”
- Also stated in: § 3. Results · plain
“Overall test performance was high, with a sensitivity of 94.8% and a specificity of 99.4%.”
§ Real‐World Evaluation of the BioFire FilmArray ME Panel: Diagnostic Accuracy and Clinical Utility > Abstract
plainn = 955- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Also stated in: § 3. Results · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Sensitivity was 91.6% in children and 97.6% in adults”
- Also stated in: § 3. Results · plain
“In pediatric patients, sensitivity and specificity were 91.6% and 99.6%, respectively”
§ Real‐World Evaluation of the BioFire FilmArray ME Panel: Diagnostic Accuracy and Clinical Utility > Abstract
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Also stated in: § 3. Results · plain
22 more claims
Create a free account to see all 49 claims and every source verdict.
- Probably not a substantial claim. 8
- It may state two separate claims as one. 16
- The quote only partly states this claim. 1
Citations
Cites
Bacterial Meningitis in the United States, 1998–2007
Thigpen, M. C., Whitney, C. G., Messonnier, N. E., Zell, E. R., Lynfield, R., Hadler, J. L., Harrison, L. H., Farley, M. M., Reingold, A., Bennett, N. M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1005384 · Cited by 953
Epidemiology, Diagnosis, and Antimicrobial Treatment of Acute Bacterial Meningitis
Brouwer, M. C., Tunkel, A. R., & van de Beek, D. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00070-09 · Cited by 930 · cited 2×
“While empirical therapy is frequently employed, accurately identifying the causative agent and promptly initiating targeted treatment are critical for optimizing patient outcomes, with the greatest clinical beneft observed when appropriate antimicrobial therapy is administered without delay [2, 3].”
Edmond, K., Clark, A., Korczak, V. S., Sanderson, C., Griffiths, U. K., & Rudan, I. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70048-7 · Cited by 631
Better Tests, Better Care: Improved Diagnostics for Infectious Diseases
Caliendo, A. M., Gilbert, D. N., Ginocchio, C. C., Hanson, K. E., May, L., Quinn, T. C., Tenover, F. C., Alland, D., Blaschke, A. J., Bonomo, R. A., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit578 · Cited by 628
Leber, A. L., Everhart, K., Balada-Llasat, J.-M., Cullison, J., Daly, J., Holt, S., Lephart, P., Salimnia, H., Schreckenberger, P. C., DesJarlais, S., et al. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.00730-16 · Cited by 609 · cited 3×
“In parallel, En-terovirus and HSV-1 represented the most commonly identifed viral agents, a pattern that is consistent with prior epidemiologic reports [6, 17].”
Spanos, A. (1989) · JAMA · doi:10.1001/jama.262.19.2700 · Cited by 436
Syndromic Panel-Based Testing in Clinical Microbiology
Ramanan, P., Bryson, A. L., Binnicker, M. J., Pritt, B. S., & Patel, R. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00024-17 · Cited by 308
Community-acquired bacterial meningitis.
van de Beek, D., Brouwer, M. C., Koedel, U., & Wall, E. C. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00883-7 · Cited by 292
Tansarli, G. S., & Chapin, K. C. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.11.016 · Cited by 263
Encephalitis hospitalization rates and inpatient mortality in the United States, 2000-2010
George, B. P., Schneider, E. B., & Venkatesan, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104169 · Cited by 263
Research works printed but not linked: 1
- 10.1001/jama.1989.03430190084036 · DOI · Paper page
Cited by
Sberna, G., D’Arezzo, S., Valli, M. B., Nisii, C., Lalle, E., Selleri, M., Brillo, F., Palazzo, C. G., Venditti, C. C., Rotondo, C., et al. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1853020
Metadata
- Authors
- Erinmez, M., Sağlam, M., Çalışkantürk, G., Özerol, M., & Zer, Y.
- Affiliations
- Gaziantep University (TR)
- Corresponding author
- Erinmez, Mehmet
- Venue
- Canadian Journal of Infectious Diseases and Medical Microbiology
- Publisher
- Wiley
- Published
- 2026-01
- Volume
- 2026
- Issue
- 1
- Pages
- 3714674-3714674
- ISSN
- 1180-2332 (ISSN-L)
- 1712-9532
- 1918-1493
- PMC
- PMC12966614
- OpenAlex
- W7134168103
- Semantic Scholar
- 478d520a2079962c1c9fe9be8fe0c5dc3d1e7978
- Cited by
- 1
- References
- 27
- Citations by year
- 2026: 1
- FWCI
- 4.59
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (vor, 64 d)
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm)
- Locations
- Canadian Journal of Infectious Diseases and Medical Microbiology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Microbiology (medical) › Bacterial Identification and Susceptibility Testing
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Health Sciences › Medicine › Infectious Diseases › Infectious Encephalopathies and Encephalitis
- Keywords
- multiplex PCR, central nervous system infection, meningitis, encephalitis, diagnostic accuracy, Streptococcus pneumoniae, enterovirus, herpes simplex virus type 1, Acinetobacter baumannii, Stenotrophomonas maltophilia, false-negative results, pediatric and adult patients
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Real‐World Evaluation of the BioFire FilmArray ME Panel: Diagnostic Accuracy and Clinical Utility. https://app.cochat.ai/papers/10.1155/cjid/3714674
- The paper
- Erinmez, M., Sağlam, M., Çalışkantürk, G., Özerol, M., & Zer, Y. (2026). Real‐World Evaluation of the BioFire FilmArray ME Panel: Diagnostic Accuracy and Clinical Utility. Canadian Journal of Infectious Diseases and Medical Microbiology. https://doi.org/10.1155/cjid/3714674
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.